Attached files
| file | filename |
|---|---|
| EX-99.1 - RESPONSE GENETICS INC | v204314_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 1,
2010
RESPONSE
GENETICS, INC.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
000-1124608
|
11-3525548
|
||
|
(State
or other
|
(Commission
File
|
(IRS
Employer
|
||
|
jurisdiction
of
|
Number)
|
Identification
No.)
|
||
|
incorporation)
|
1640
Marengo St., 6th Floor
Los
Angeles, California 90033
(323)
224-3900
(Address,
including zip code, and telephone number, including area code, of registrant’s
principal
executive offices)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
|
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01. Regulation FD Disclosure.
On
December 1, 2010, in connection with its annual meeting, Response Genetics, Inc.
(the “Company”)
made a slideshow presentation to the shareholders in attendance at the
meeting. A copy of the slideshow presentation is attached to this
report as Exhibit 99.1. The information in this Current Report on
Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for
purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”) or otherwise subject to the liabilities of that section, nor shall they be
deemed incorporated by reference in any filing under the Securities Act of 1933
or the Exchange Act, except as expressly set forth by specific reference in such
a filing.
Item
9.01. Financial Statements and Exhibits.
|
(c)
|
Exhibits.
|
|
Exhibit #
|
Description
|
|
|
99.1*
|
|
Copy
of the Shareholders Presentation, presented on December 1,
2010
|
|
*
|
Exhibit
99.1 is being furnished to the Securities and Exchange Commission (the
“SEC”) pursuant to Item 7.01 and is not being filed with the SEC.
Therefore, this exhibit is not incorporated by reference in any of the
registrant’s other SEC filings.
|
- 2
-
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
RESPONSE
GENETICS, INC.
|
||
|
Date:
December 1, 2010
|
By:
|
/s/ Denise McNairn
|
|
Name:
Denise McNairn
|
||
|
Title:
Vice President, General Counsel and
Secretary
|
||